Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK1 | P06493 | 16/20 | 0.71 |
| ▸ | CDK5 | Q00535 | 11/20 | 0.71 |
| ▸ | CDK2 | P24941 | 8/20 | 0.68 |
| ▸ | FLT3 | P36888 | 1/20 | 0.59 |
| ▸ | CCNE1 | P24864 | 3/20 | 0.58 |
| ▸ | CCNE2 | O96020 | 2/20 | 0.58 |
| ▸ | CDK9 | P50750 | 4/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.56 |
| ▸ | NPC1 | O15118 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | CSNK1D | P48730 | 3/20 | 0.55 |
| ▸ | CLK2 | P49760 | 3/20 | 0.55 |
| ▸ | DYRK1A | Q13627 | 3/20 | 0.55 |
| ▸ | CLK4 | Q9HAZ1 | 3/20 | 0.55 |
| ▸ | HIPK4 | Q8NE63 | 2/20 | 0.55 |
| ▸ | SRPK1 | Q96SB4 | 2/20 | 0.55 |
| ▸ | CDK7 | P50613 | 3/20 | 0.54 |
| ▸ | CSNK1G2 | P78368 | 2/20 | 0.54 |
| ▸ | CSNK1G1 | Q9HCP0 | 2/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6016542 | 1.00 | CDK1 (0.71) | CDK1CDK5CDK2FLT3CCNE1 | |
| SCHEMBL6016588 | 1.00 | CDK1 (0.71) | CDK1CDK5CDK2FLT3CCNE1 | |
| SCHEMBL6016536 | 0.89 | CDK1 (0.72) | CDK1CDK5CDK2CCNE1CCNE2 | |
| SCHEMBL6016531 | 0.89 | CDK1 (0.72) | CDK1CDK5CDK2CCNE1CCNE2 | |
| SCHEMBL6016491 | 0.85 | CDK5 (0.72) | CDK1CDK5CDK2CCNE1CCNE2 | |
| SCHEMBL6016657 | 0.85 | CDK5 (0.72) | CDK1CDK5CDK2CCNE1CCNE2 | |
| SCHEMBL6016726 | 0.85 | CDK5 (0.72) | CDK1CDK5CDK2CCNE1CCNE2 | |
| SCHEMBL6016494 | 0.85 | CDK5 (0.72) | CDK1CDK5CDK2CCNE1CCNE2 | |
| SCHEMBL6016653 | 0.85 | CDK5 (0.72) | CDK1CDK5CDK2CCNE1CCNE2 | |
| SCHEMBL6016435 | 0.85 | CDK1 (0.66) | CDK1CDK5CDK2CCNE1CCNE2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1244668-B1 | PURINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND USE THEREOF | UNIVERSITAIRE INSTELLING ANTWE (BE) | 2006-04-05 | — | — | EP | disclosed |
| US-20030187261-A1 | Purine derivatives, process for their preparation and use thereof | USTAV EXPERIMANTALNI BOTANIKY AKADEMIE VED CESKE REPUBLIKY (CZ) | 2003-10-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030187261-A1 | Purine derivatives, process for their preparation and use thereof | DCK, DTYMK, CCNK | CDK1 7/4885CDK5 23/4885CDK2 9/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.